---
title: "Gefjon Pharma ApS – CVR 44512971, financials and ownership"
description: "Gefjon Pharma ApS (CVR 44512971). Active · Fremstilling af farmaceutiske præparater · København N. 6 employees (CVR) (Aug 2026). Gross profit -2.2M DKK (2026)."
canonical_url: "https://datapublica.dk/en/companies/44512971-gefjon-pharma-aps"
locale: "en"
route_type: "company_overview"
robots: "index,follow"
---

# Gefjon Pharma ApS

Gefjon Pharma ApS \(CVR 44512971\). Active · Fremstilling af farmaceutiske præparater · København N. 6 employees \(CVR\) \(Aug 2026\). Gross profit -2.2M DKK \(2026\).

CVR number: 44512971

## Company details

- **CVR number:** 44512971

- **Status:** Aktiv

- **Address:** Ole Maaløes Vej 3, 2200, København N

- **Legal form:** Anpartsselskab \(ApS\)

- **Founded:** Dec 19, 2023

- **Employees / FTEs:** 6 / 4

- **Production units:** 1

- **Website:** https://www.gefjonpharma.com/

## Activities and industry

- Fremstilling af farmaceutiske præparater

- 212000 — Fremstilling af farmaceutiske præparater

## Latest financial period

- **Reporting period:** 2025/26 \(1 Apr 2025 - 31 Mar 2026\)

- **Currency:** DKK

- **Gross profit:** -2,230,382

- **Operating profit:** -4,402,019

- **Profit after tax:** -4,245,453

- **Assets:** 7,867,883

- **Equity:** -4,998,334

## People

| Person | Roles | Titles |
| --- | --- | --- |
| [Anders Miki Bojesen](https://datapublica.dk/en/people/pid_entity_4004182113-anders-miki-bojesen) | Board • Management | FORMAND • DIREKTØR |
| [Fabio Antenucci](https://datapublica.dk/en/people/pid_entity_4009822482-fabio-antenucci) | Board • Management | BESTYRELSESMEDLEM • DIREKTØR |
| [Thomas Frees Buthler](https://datapublica.dk/en/people/pid_entity_4004086156-thomas-frees-buthler) | Board • Management | BESTYRELSESMEDLEM • DIREKTØR |
| [Torben Hald](https://datapublica.dk/en/people/pid_entity_4009816416-torben-hald) | Board • Management | BESTYRELSESMEDLEM • ADM. DIR. |

## Auditor

| Audit firm | Auditor | Role | From |
| --- | --- | --- | --- |
| PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab | Peter Skole-Sørensen | State Authorised Public Accountant | Aug 14, 2026 |
| PricewaterhouseCoopersStatsautoriseret Revisionspartnerselskab | André Nielsen | State Authorised Public Accountant | Aug 14, 2026 |

## Contact

### From [cvr.dk](https://datacvr.virk.dk/)

Advertising protected

Contact details from CVR must not be used for direct marketing when the entity is advertising protected. The protection does not cover details collected from the company’s own website. The general marketing rules still apply. [Read more at the Danish Business Authority](https://virksomhedsguiden.dk/content/ydelser/faa-reklamebeskyttet-din-virksomhed-i-cvr/3337006d-3b93-4bb0-bc08-82a0915c0332/)

| Contact | Phone | Email |
| --- | --- | --- |
| Company | 5089\*\*\*\* [Show full](https://datapublica.dk/en/signup?redirectTo=%2Fen%2Fcompanies%2F44512971-gefjon-pharma-aps) | th\*\*\*\*@gefjonpharma.com [Show full](https://datapublica.dk/en/signup?redirectTo=%2Fen%2Fcompanies%2F44512971-gefjon-pharma-aps) |

## Legal owners

### Current

| Owner | Ownership | Voting rights | From |
| --- | --- | --- | --- |
| OwnerCopenhagen Equity ApS | Ownership25–33.32 % | Voting rights25 % | FromDec 19, 2023 |
| OwnerHAVITO AS | Ownership25–33.32 % | Voting rights25 % | FromDec 19, 2023 |
| OwnerNorth2k ApS | Ownership25–33.32 % | Voting rights25 % | FromDec 19, 2023 |
| OwnerTBU Holding 2023 ApS | Ownership25–33.32 % | Voting rights25 % | FromDec 19, 2023 |

## Ultimate owners
[View ownership diagram](https://datapublica.dk/en/companies/44512971-gefjon-pharma-aps/portfolio)
| Name | Ownership through | Calculated ownership |
| --- | --- | --- |
| Anders Miki Bojesen | Copenhagen Equity ApS | 25–33.32 % |
| Fabio Antenucci | North2k ApS | 25–33.32 % |
| HAVITO AS | Direct | 25–33.32 % |
| Thomas Frees Buthler | TBU Holding 2023 ApS | 25–33.32 % |

## Company pages

- [Overview](https://datapublica.dk/en/companies/44512971-gefjon-pharma-aps)

- [Financial report](https://datapublica.dk/en/companies/44512971-gefjon-pharma-aps/financials)

- [Risk](https://datapublica.dk/en/companies/44512971-gefjon-pharma-aps/risk)

- [Timeline](https://datapublica.dk/en/companies/44512971-gefjon-pharma-aps/timeline)

- [Ownership and relations](https://datapublica.dk/en/companies/44512971-gefjon-pharma-aps/portfolio)

- [Production units](https://datapublica.dk/en/companies/44512971-gefjon-pharma-aps/production-units)

- [Gazelle](https://datapublica.dk/en/companies/44512971-gefjon-pharma-aps/gazelle)

- [Investments](https://datapublica.dk/en/companies/44512971-gefjon-pharma-aps/investments)

- [Company website](https://www.gefjonpharma.com/)

## Official sources

- [Official CVR record on Virk](https://datacvr.virk.dk/enhed/virksomhed/44512971)